Stratos Wealth Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,106
Closed -$1.78M 667
2023
Q2
$1.78M Hold
4,106
0.13% 215
2023
Q1
$2.44M Hold
4,106
0.19% 146
2022
Q4
$1.66M Sell
4,106
-616
-13% -$289K 0.14% 204
2022
Q3
$2.77M Buy
4,722
+4
+0.1% +$2.4K 0.29% 98
2022
Q2
$2.58M Buy
4,718
+3,846
+441% +$1.95M 0.23% 113
2022
Q1
$553K Hold
872
0.04% 359
2021
Q4
$589K Buy
+872
New +$531K 0.04% 368

Other funds holding AGL

Stratos Wealth Advisors's AGL Position: Q3 2023 in Review

Stratos Wealth Advisors sold out of Agilon Health (AGL) in Q3 2023, closing a stake of 4,106 shares — an estimated $1.78M sold.

Stratos Wealth Advisors first reported a position in AGL in Q4 2021 and held it in 7 quarters. The position peaked at $2.77M in Q3 2022. 177 funds tracked by Wall St. Rank hold AGL as of Q3 2023.

  • Stratos Wealth Advisors reported no remaining Agilon Health position as of Q3 2023 after selling out during the quarter.
  • Stratos Wealth Advisors sold 4,106 Agilon Health shares in Q3 2023, an estimated $1.78M.
  • Stratos Wealth Advisors first reported a position in Agilon Health in Q4 2021 and held it in 7 quarters.
  • Stratos Wealth Advisors's Agilon Health position peaked at $2.77M in Q3 2022.
  • 177 funds tracked by Wall St. Rank held Agilon Health as of Q3 2023.

Based on Stratos Wealth Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.